2025 UVA Controversies in Liver Disease and Transplantation

Registration open!

In this one day conference, a team of multi-disciplinary experts will present on topics relevant for practicing gastroenterologists, hepatologists, primary care physicians, physician assistants, advanced practice providers, nurses, and anyone involved with providing patient care for liver disease before, during and after transplantation. We will explore the latest developments in organ recovery, innovative treatments for liver tumors, and evolving guidelines in transplant decision-making. Expert-led sessions will highlight emerging techniques such as normothermic and regional perfusion, histotripsy, and strategies for managing alcohol-associated liver disease. Attendees will engage with case studies and dynamic Q&A sessions designed to drive equitable, expert patient care.

Saturday, September 27, 2025, 7:15 AM - 2:30 PM EST, Omni Hotel, Charlottesville, VA

1. Demonstrate effective communication techniques to approach and engage donor families in end of life discussions with empathy, respect and cultural sensitivity.
2. Evaluate the role of the donor care unit in optimizing organ recovery, focusing on medical management, post-mortem care and interventions that maximize donor organ quality and availability.
3. Describe the evolving technologies and methodologies related to deceased donor organ recovery including advancements in preservation, machine perfusion, and organ viability assessment.
4. Assess the feasibility and risks associated with transplanting medically complex organs, taking into account donor history, organ function and recipient suitability.
5. Identify key factors contributing to geographic disparities in liver transplant availability, transplantation rates and access to healthcare resources.
6. Explain latest advancements in interventional radiology techniques for the diagnosis and treatment of liver tumors.
7. Identify key factors influencing surgical decisions in cirrhotic patients.
8. Discuss the unique challenges of anesthesia management in liver transplant recipients.
9. Analyze diagnostic and therapeutic strategies for managing PVT in both transplant and non-transplant candidates, including its effect on liver transplant feasibility and outcomes.
10. Describe the standard evaluation and classification of portal vein thrombosis (PVT) and its impact on prognosis in cirrhotic patients.
11. Define post-transplant MASH and understand it's pathophysiology.
12. Describe the indications for TIPS including role in managing portal hypertension, variceal bleeding and refractory ascites.
13. Recognize the relationship between frailty and liver transplantation, focusing on frailty as a predictor of surgical complications, prolonged hospital stay and post-transplant morbidity.

AMA PRA Category 1 Credits™ (5.00 hours), AAPA (5.00 hours), ANCC Contact Hours (5.00 hours), CEPTC Category 1 (5.00 hours), Hours of Participation (5.00 hours), IPCE (5.00 hours), Social Work ASWB-General (5.00 hours)

Participant Rates:

Attendee Type	Thru 9/7/25	9/8/25-9/21/25
Physician (In Person or Virtual)	$180	$230
Other HCP * (In Person or Virtual) *Includes Residents, Fellows or Students	$80	$130

Cancellation Policy

Cancellation requests received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be provided for cancellation requests received within 30 days or for registration fees of less than $50.  Please send cancellation requests [email protected].

 

UVA Health Continuing Education reserves the right to cancel CE activities if necessary.  In this case, the entire registration fee will be refunded.  All other expenses incurred in conjunction with this CE activity are the sole responsibility of the participant.

Accessibility Statement
 
UVACE is committed to ensuring equal access to educational opportunities for individuals with disabilities, in compliance with the Americans with Disabilities Act of 1990 (ADA), as amended, and Section 504 of the Rehabilitation Act of 1973 (Section 504), as well as other applicable state and local laws and University policy. Individuals with disabilities are entitled to reasonable accommodations to ensure their participation in courses. Please note that some of the course venues at UVA are registered historic properties and may not be fully ADA accessible. If you have needs that require special accommodation, including dietary concerns, please email [email protected].  All requests must be received 30 days prior to the course start date.

In support of improving patient care, UVA Health Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

UVA Health Continuing Education adheres to the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

To view financial disclosures, select the faculty name below. 

Saturday, September 27, 2025

Exhibit Opportunity Letter

Copy of Promotion and Exhibit Agreement

W-9

Exhibit at this Event